Unjha Formulations Ltd
Fundamental Score
Unjha Formulations Ltd Share Price Live NSE/BSE
Profitability Metrics
Return on Equity
Return on Capital Employed
Operating Profit Margin (5Y)
Dividend Yield
Valuation Metrics
Price to Earnings
Market Capitalization
Industry P/E
Growth Metrics
YoY Quarterly Profit Growth
YoY Quarterly Sales Growth
Sales Growth (5Y)
EPS Growth (5Y)
Profit Growth (5Y)
Financial Health
Debt to Equity
Interest Coverage
Free Cash Flow (5Y)
Ownership Structure
Promoter Holding
FII Holding
DII Holding
Pledged Percentage
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Market Data Analysis & Educational Insights
Educational evaluation of UNJHAFOR across key market metrics for learning purposes.
Positive Indicators
5 factors identified
Excellent ROCE Performance (18.06%)
Observation: Superior returns on capital employed across business operations.
Analysis: ROCE >15% demonstrates efficient capital deployment and strong operational performance. This indicates quality business fundamentals.
Attractive Valuation (P/E: 10.74 vs Industry: 31.77)
Observation: Trading at discount to industry peers.
Analysis: P/E below industry average may present value opportunity if fundamentals support the business case.
Robust Profit Growth (845.45%)
Observation: Strong year-over-year profit expansion demonstrates business momentum.
Analysis: Profit growth >20% indicates effective execution and market opportunity capture. This suggests positive business trajectory.
Debt-Free Balance Sheet (D/E: 0.00)
Observation: Low leverage provides financial flexibility and reduced risk.
Analysis: Conservative debt structure offers resilience during economic downturns and flexibility for growth investments.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral, reducing forced-selling risk.
Analysis: Absence of share pledging eliminates potential forced-selling pressure during market stress.
Risk Factors
4 factors identified
Margin Pressure Concerns (2.84%)
Observation: Operating margins are below industry standards.
Analysis: OPM <5% may indicate pricing pressures or cost management challenges. Monitor for operational improvements.
Negative Free Cash Flow (₹-0.16 Cr over 5Y)
Observation: Cash outflows exceed inflows, indicating capital intensity or working capital issues.
Analysis: Negative FCF requires analysis of capital expenditure cycle and working capital management efficiency.
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints. Assess capital allocation strategy.
Small Market Cap
Observation: Higher investment risk due to limited size.
Analysis: Small-cap stocks typically carry higher volatility and liquidity risks.
Financial Statements
Comprehensive financial data for Unjha Formulations Ltd
About UNJHAFOR
Business Overview
Unjha Formulations Limited manufactures and sells ayurvedic products in India. The company offers sat-isabgol and isabgo husk formulation in elaichi flavor under the Anchor name; and isabgol powder in orange flavor under the Fibron and Fibron SF names. It also exports its products. Unjha Formulations Limited was incorporated in 1994 and is based in Sidhpur, India.
Company Details
Key Leadership
UNJHAFOR Stock Details & Analysis
Key Financial Metrics
Growth & Valuation
Frequently Asked Questions
What is the current price of Unjha Formulations Ltd (UNJHAFOR)?
As of 21 Jan 2026, 08:49 am IST, Unjha Formulations Ltd (UNJHAFOR) is currently trading at ₹21.00. The stock has a market capitalization of ₹10.96 (Cr).
Is UNJHAFOR share price Overvalued or Undervalued?
UNJHAFOR is currently trading at a P/E ratio of 10.74x, compared to the industry average of 31.77x. Based on this relative valuation, the stock appears to be Undervalued against its sector peers.
What factors affect the Unjha Formulations Ltd share price?
Key factors influencing UNJHAFOR's price include its quarterly earnings growth (Sales Growth: 13.49%), raw material costs, government infrastructure spending, and institutional flows (FII/DII holding).
Is Unjha Formulations Ltd a good stock for long-term investment?
Unjha Formulations Ltd shows a 5-year Profit Growth of 5.75% and an ROE of 13.97%. Long-term investors should consider these fundamentals alongside the debt-to-equity ratio of 0.00 before investing.
How does Unjha Formulations Ltd compare with its industry peers?
Unjha Formulations Ltd competes with major peers in the Pharmaceuticals. Investors should compare UNJHAFOR's P/E of 10.74x and ROE of 13.97% against the industry averages to determine its competitive standing.
What is the P/E ratio of UNJHAFOR and what does it mean?
UNJHAFOR has a P/E ratio of 10.74x compared to the industry average of 31.77x. The Price-to-Earnings (P/E) ratio is calculated by dividing the current share price by earnings per share (EPS). This means investors are paying ₹11 for every ₹1 of annual earnings.
How is UNJHAFOR performing according to Bull Run's analysis?
UNJHAFOR has a Bull Run fundamental score of 38.8/100, which indicates concerns that require careful analysis. This comprehensive rating is based on 15+ financial parameters including profitability, growth metrics, and valuation ratios.
What sector and industry does UNJHAFOR belong to?
UNJHAFOR operates in the Pharmaceuticals industry. This classification helps understand the competitive landscape and sector-specific trends affecting Unjha Formulations Ltd.
What is Return on Equity (ROE) and why is it important for UNJHAFOR?
UNJHAFOR has an ROE of 13.97%, which shows decent profitability but room for improvement. Return on Equity measures how efficiently Unjha Formulations Ltd generates profits from shareholders' equity.
How is UNJHAFOR's debt-to-equity ratio and what does it indicate?
UNJHAFOR has a debt-to-equity ratio of 0.00, which indicates conservative financing with low financial risk. A ratio below 1.0 generally indicates conservative financing.
What is UNJHAFOR's dividend yield and is it a good dividend stock?
UNJHAFOR offers a dividend yield of 0.00%, which means you receive ₹0.00 annual dividend for every ₹100 invested.
How has UNJHAFOR grown over the past 5 years?
UNJHAFOR has achieved 5-year growth rates of: Sales Growth 5.53%, Profit Growth 5.75%, and EPS Growth 5.75%.
What is the promoter holding in UNJHAFOR and why does it matter?
Promoters hold 36.92% of UNJHAFOR shares, with 0.00% of promoter shares pledged. High promoter holding often indicates strong management confidence.
What is UNJHAFOR's market capitalization category?
UNJHAFOR has a market capitalization of ₹11 crores, placing it in the Small-cap category.
How volatile is UNJHAFOR stock?
UNJHAFOR has a beta of N/A. A beta > 1 suggests the stock is more volatile than the market, while a beta < 1 suggests it is less volatile.
What is the 52-week high and low for UNJHAFOR?
UNJHAFOR has a 52-week high of ₹N/A and low of ₹N/A.
What is UNJHAFOR's operating profit margin trend?
UNJHAFOR has a 5-year average Operating Profit Margin (OPM) of 2.84%, indicating the company's operational efficiency.
How is UNJHAFOR's quarterly performance?
Recent quarterly performance shows YoY Sales Growth of 13.49% and YoY Profit Growth of 845.45%.
What is the institutional holding pattern in UNJHAFOR?
UNJHAFOR has FII holding of 0.00% and DII holding of 0.00%. Significant institutional holding often suggests professional confidence in the stock.